Metastatic breast cancer patients feel excluded from awareness campaigns like Pinktober, despite billions raised for research—discover why funding priorities mi

FDA approves Jaypirca (pirtobrutinib) as the first noncovalent BTK inhibitor for frontline CLL and SLL treatment in patients without 17p deletion.

New phase 3 cancer trial results show longer survival for several tumor types, with ivonescimab achieving a median survival of 30.8 months in NSCLC.

New 10-year data shows three-week post-mastectomy radiation equals five-week cancer control for high-risk breast cancer patients, per ASTRO 2026 findings.

AI helps doctors with cancer care questions, potentially extending beyond oncologists and cancer specialists.

Woman battles stage 4 lymphoma diagnosis with aggressive treatment options for non-Hodgkin lymphoma.

Bronx author discovers lung cancer faith after a 2023 diagnosis, sharing her journey from a Santería-rich upbringing to embracing Christianity.

Kazia Therapeutics expands its clinical trial of paxalisib for advanced breast cancer, focusing on safety and tolerability.

Leukemia returns even after aggressive treatment in children. Researchers at Roswell Park are studying why this happens and how to stop it.

Mindfulness and Tai Chi practices may ease fatigue and pain in cancer survivors, according to a recent clinical study.